Question 1

What are the potential side effects of LY2784544?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms clinical trial (NCT01520220). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms clinical trial (NCT01520220). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my participation involve in terms of visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms clinical trial (NCT01520220). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to take the study drug?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms clinical trial (NCT01520220). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms clinical trial (NCT01520220). Contact the study team or your healthcare provider for specific answers.

What this study is about